CH539021A - Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen - Google Patents

Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen

Info

Publication number
CH539021A
CH539021A CH1500471A CH1500471A CH539021A CH 539021 A CH539021 A CH 539021A CH 1500471 A CH1500471 A CH 1500471A CH 1500471 A CH1500471 A CH 1500471A CH 539021 A CH539021 A CH 539021A
Authority
CH
Switzerland
Prior art keywords
compounds
preparation
acid production
gastric acid
inhibit gastric
Prior art date
Application number
CH1500471A
Other languages
English (en)
Inventor
Elof Brandstrom Arne
Krister Junggren Ulf
Robert Lamm Bo
Erik Wilander Bengt
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of CH539021A publication Critical patent/CH539021A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1500471A 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen CH539021A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2778768A GB1279412A (en) 1968-06-11 1968-06-11 Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion

Publications (1)

Publication Number Publication Date
CH539021A true CH539021A (de) 1973-08-31

Family

ID=10265313

Family Applications (2)

Application Number Title Priority Date Filing Date
CH880769A CH525193A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH1500471A CH539021A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH880769A CH525193A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen

Country Status (11)

Country Link
AT (6) AT293430B (de)
BE (1) BE734033A (de)
BR (1) BR6909672D0 (de)
CH (2) CH525193A (de)
DE (1) DE1929416A1 (de)
DK (1) DK126035B (de)
ES (3) ES368207A1 (de)
FR (2) FR2010650B1 (de)
GB (1) GB1279412A (de)
IE (1) IE33149B1 (de)
NL (1) NL6908843A (de)

Also Published As

Publication number Publication date
DK126035B (da) 1973-06-04
AT298667B (de) 1972-05-25
AT293428B (de) 1971-10-11
NL6908843A (de) 1969-12-15
ES388702A1 (es) 1973-05-16
CH525193A (de) 1972-07-15
AT293430B (de) 1971-10-11
IE33149L (en) 1969-12-11
FR2010650A1 (de) 1970-02-20
IE33149B1 (en) 1974-04-03
AT294849B (de) 1971-12-10
ES388703A1 (es) 1974-02-16
ES368207A1 (es) 1972-04-16
DE1929416A1 (de) 1970-07-16
AT292012B (de) 1971-08-10
FR2010650B1 (de) 1975-01-10
BR6909672D0 (pt) 1973-03-13
GB1279412A (en) 1972-06-28
AT293429B (de) 1971-10-11
BE734033A (de) 1969-11-17
FR2140246A1 (de) 1973-01-12

Similar Documents

Publication Publication Date Title
CH556319A (de) Verfahren zur herstellung von neuartigen substituierten trizyklischen carbonsaeureverbindungen.
CH556329A (de) Verfahren zur herstellung von cyanacrylsaeureestern.
CH496641A (de) Verfahren zur Herstellung von Lavandulylsäure
CH552551A (de) Verfahren zur herstellung von laevulinsaeure.
CH550133A (de) Verfahren zur herstellung von 4-methyl-pentanol-2-crotonat.
CH522961A (de) Verfahren zur Herstellung isolierter Halbleiterbereiche
AT301486B (de) Verfahren zur Herstellung von Phosphorsäure
CH551373A (de) Verfahren zur herstellung von bronchospasmolytisch wirksamen verbindungen.
CH548421A (de) Verfahren zur herstellung von nitrilo-tris-(methylenphosphonsaeure).
AT307747B (de) Verfahren zur Herstellung von Polykondensationsprodukten aus Hydroxymethyl-phosphoniumverbindungen
CH550214A (de) Verfahren zur herstellung von cyclocopolymerisaten.
CH529128A (de) Verfahren zur Herstellung von Tetronsäure
AT303093B (de) Verfahren zur Herstellung von gekörnten Düngemitteln
CH558385A (de) Verfahren zur herstellung von ungesaettigten phosphorhaltigen carbonsaeurederivaten.
CH553242A (de) Verfahren zur herstellung von fluoreszierenden verbindungen.
CH525193A (de) Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH534668A (de) Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH549567A (de) Verfahren zur herstellung von 8-cyano-5-octanolid.
CH558800A (de) Verfahren zur herstellung von chinazolinonen.
CH547775A (de) Verfahren zur herstellung von diaethylaminopropionaniliden.
CH557830A (de) Verfahren zur herstellung von 1-aminosiochinolinen.
CH557327A (de) Verfahren zur herstellung von neuen 1-methylaminoalkyliden-benzocycloalkan-2-spirocycloaliphatischen verbindungen.
CH515783A (de) Verfahren zur Herstellung hygienisch-sanitärer Geräte
AT310462B (de) Verfahren zur Herstellung intermetallischer Verbindungen
CH553744A (de) Verfahren zur herstellung aromatischer dinitrohalogenverbindungen.

Legal Events

Date Code Title Description
PL Patent ceased